Development and evaluation of occlusive systems employing polyvinyl alcohol for transdermal delivery of sumatriptan succinate

References

• Balaguer-Fernández, C., Femenía-Font, A., del Rio-Sancho S., Merino V., López-Castellano A. (2007). Sumatriptan succinate transdermal delivery systems for the treatment of migraine. J Pharm Sci. 97:2102–9.
   Web of Science ®Google Scholar
• Barry, B.W. (1983). Properties that influence percutaneus absorption. In: Dermatological formulations: percutaneous absorption. Editor: Barry BW. New York: Marcel Dekker, 181–2.
   Google Scholar
• Belvis, R., Pagonabarraga, J., Kulisevsky, J. (2009). Individual triptan selection in migraine attack therapy. Recent Pat CNS Drug Discov. 4:70–81.
   PubMedGoogle Scholar
• Berti, J.J., Lipsky, J.J. (1995). Transcutaneous drug delivery: a practical review. Mayo Clin Proc. 70:581–6.
   PubMed Web of Science ®Google Scholar
• Bigal, M.E., Krymchantowski, A.V., Hargreaves, R. (2009). The triptans. Expert Rev Neurother. 9:649–59.
   PubMed Web of Science ®Google Scholar
• Chien, Y.W. (1987). Development concepts and practice in transdermal therapeutic systems. In: Chien, Y.W., ed. Transdermal controlled systemic medications. New York: Marcel Dekker, 25–81.
   Google Scholar
• Dick, I.P., Scott, R.C. (1992). Pig ear skin as an in vitro model for human skin permeability. J Pharm Pharmacol. 44: 640–5.
   PubMed Web of Science ®Google Scholar
• Femenía-Font, A., Balaguer-Fernández, C., Merino, V., López-Castellano, A. (2006b). Combination strategies for enhancing transdermal absorption of sumatriptan through skin. Int J Pharm. 323:125–30.
   PubMed Web of Science ®Google Scholar
• Femenía-Font, A., Balaguer-Fernández, C., Merino, V., Rodilla, V., López-Castellano, A. (2005a). Effect of chemical enhancers on the in vitro percutaneus absorption of sumatriptan succinate. Eur J Pharm Biopharm. 61:50–5.
   PubMed Web of Science ®Google Scholar
• Femenía-Font, A., Merino, V., Rodilla, V., López-Castellano, A. (2005b). High-performance liquid chromatographic determination of sumatriptan after in vitro transdermal diffusion studies. J Pharm Biomed Anal. 37: 621–6.
   PubMed Web of Science ®Google Scholar
• Femenía-Font, A., Padula, C., Marra, F., Balaguer-Fernández, C., Merino, V., López-Castellano, A., Nicoli, S., Santi, P. (2006a). Bioadhesive monolayer system for the in vitro transdermal delivery of sumatriptan. J Pharm Sci. 95:1561–9.
   PubMed Web of Science ®Google Scholar
• Glenview, I.L. (1976). Test methods for pressure sensitive tapes; 7th ed. Pressure Sensitive Tape Council. Specifications and Technical Committee. The Council; Glenview, Ill. USA.
   Google Scholar
• Godin, B., Touitou, E. (2007). Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev. 59:1152–61.
   PubMed Web of Science ®Google Scholar
• Peh, K., Khan, T., Ch’ng, H. (2000). Mechanical, bioadhesive strength and biological evaluations of chitosan films for wound dressing. J Pharm Pharm Sci. 3:303–11.
   PubMed Web of Science ®Google Scholar
• López, A., Llinares, F., Cortell, C., Herráez, M. (2000). Comparative enhancer effects of Span 20® with Tween 20® and Azone® on the in vitro percutaneous penetration of compounds with different lipophilicities. Int J Pharm. 202:133–40.
   PubMed Web of Science ®Google Scholar
• López-Cervantes, M., Márquez-Mejía, E., Cázares-Delgadillo, J., Quintanar-Guerrero, D., Ganem-Quintanar, A., Angeles-Anguiano, E. (2006). Chemical enhancers for the absorption of substances through the skin: laurocapram and its derivatives. Drug Dev Ind Pharm. 32:267–86.
   PubMed Web of Science ®Google Scholar
• Nicoli, S., Penna, E., Padula, C., Colombo, P., Santi, P. (2006). New transdermal bioadhesive system containing oxybutynin: in vitro permeation across rabbit ear skin. Int J Pharm. 325:2–7.
   PubMed Web of Science ®Google Scholar
• Padula, C., Colombo, G., Nicoli, S., Catellani, P.L., Massimo, G., Santi, P. (2003). Bioadhesive system for the transdermal delivery of lidocaine: in vitro and in vivo behavior. J Control Release. 88:277–85.
   PubMed Web of Science ®Google Scholar
• Padula, C., Nicoli, S., Aversa, V., Colombo, P., Falson, F., Pirot, F., Santi, P. (2004). Bioadhesive system for dermal and transdermal drug delivery. Eur J Dermatol. 17:309–12.
   Google Scholar
• Padula, C., Nicoli, S., Santi, P. (2009). Innovative formulations for the delivery of levothyroxine to the skin. Int J Pharm. 372:12–6.
   PubMed Web of Science ®Google Scholar
• Pathan, I.B., Setty, C.M. (2009). Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pham Res. 8:173–9.
   Web of Science ®Google Scholar
• Scott, A.K. (1994). Sumatriptan clinical pharmacokinetics. Clin Pharmacokinet. 27:337–44.
   PubMed Web of Science ®Google Scholar
• Simon, G.A., Maibach, H.I. (2000). The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations—an overview. Skin Pharmacol Appl Skin Physiol. 13:229–234.
   PubMedGoogle Scholar
• Smith, E.W., Maibach, H.I. (1995). Azone®. In: Smith, E.W., Maibach, H.I., eds. Percutaneous penetration enhancers. Boca Raton: CRC Press, 129–30.
   Google Scholar
• Sugibayashi, K., Nakayama, S., Seki, T., Hosoya, K., Morimoto, Y. (1992). Mechanism of skin penetration-enhancing effect by laurocapram. J Pharm Sci. 81:58–64.
   PubMed Web of Science ®Google Scholar
• Tanner, T., Marks, R. (2008). Delivering drugs by the transdermal route: review and comment. Skin Res Technol. 14:249–260.
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen, P., De Vries, P., Saxena, P.R. (2000). Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60:1259–87.
   PubMed Web of Science ®Google Scholar
• Ubaidulla, U., Reddy, M.V., Ruckmani, K., Ahmad, F.J., Khar, R.K. (2007). Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics. AAPS PharmSciTech. 8: Article 2.
   PubMed Web of Science ®Google Scholar
• Walters, K.A., Hadgraft, J. (1993). Azone®: mechanism of action and clinical effect. In: Walters, K.A., Hadgraft, J., eds. Pharmaceutical skin penetration enhancement. Vol. 59. New York: Marcel Dekker, 175–7.
   Google Scholar